Učitavanje...
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
BACKGROUND/AIMS: Cystinosis is a rare, autosomal recessive disorder causing defective transport of cystine out of lysosomes. Cystadrops (0.55% cysteamine hydrochloride in viscous solution) has been used on a named-patient basis to treat the accumulation of cystine crystals in the cornea in patients...
Spremljeno u:
| Izdano u: | Br J Ophthalmol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8077218/ https://ncbi.nlm.nih.gov/pubmed/32593979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316450 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|